MAC Lung Disease clinical trials at UCSF
1 research study open to eligible people
Mycobacterium avium complex lung disease is an infection that can cause serious problems in the lungs. UCSF is evaluating a new treatment using Clofazimine that is inhaled. The goal is to determine its safety and effectiveness for patients with this condition.
Showing trials for
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
open to eligible people ages 18-85
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Fresno, California and other locations
Our lead scientists for MAC Lung Disease research studies include Mohamed Fayed, MD, FCCP.
Last updated: